TY - JOUR A1 - Schulze, Markus A1 - Hutterer, Maria A1 - Sabo, Anja A1 - Hoja, Sabine A1 - Lorenz, Julia A1 - Rothhammer-Hampl, Tanja A1 - Herold-Mende, Christel A1 - Floßbach, Lucia A1 - Monoranu, Camelia A1 - Riemenschneider, Markus J. T1 - Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions JF - BMC Cancer N2 - Background The phosphatase chronophin (CIN/PDXP) has been shown to be an important regulator of glioma cell migration and invasion. It has two known substrates: p-Ser3-cofilin, the phosphorylated form of the actin binding protein cofilin, and pyridoxal 5′-phosphate, the active form of vitamin B6. Phosphoregulation of cofilin, among other functions, plays an important role in cell migration, whereas active vitamin B6 is a cofactor for more than one hundred enzymatic reactions. The role of CIN has yet only been examined in glioblastoma cell line models derived under serum culture conditions. Results We found that CIN is highly expressed in cells cultured under non-adherent, serum-free conditions that are thought to better mimic the in vivo situation. Furthermore, the substrates of CIN, p-Ser3-cofilin and active vitamin B6, were significantly reduced as compared to cell lines cultured in serum-containing medium. To further examine its molecular role we stably knocked down the CIN protein with two different shRNA hairpins in the glioblastoma cell lines NCH421k and NCH644. Both cell lines did not show any significant alterations in proliferation but expression of differentiation markers (such as GFAP or TUBB3) was increased in the knockdown cell lines. In addition, colony formation was significantly impaired in NCH644. Of note, in both cell lines CIN knockdown increased active vitamin B6 levels with vitamin B6 being known to be important for S-adenosylmethionine biosynthesis. Nevertheless, global histone and DNA methylation remained unaltered as was chemoresistance towards temozolomide. To further elucidate the role of phosphocofilin in glioblastoma cells we applied inhibitors for ROCK1/2 and LIMK1/2 to our model. LIMK- and ROCK-inhibitor treatment alone was not toxic for glioblastoma cells. However, it had profound, but antagonistic effects in NCH421k and NCH644 under chemotherapy. Conclusion In non-adherent glioblastoma cell lines cultured in serum-free medium, chronophin knockdown induces phenotypic changes, e.g. in colony formation and transcription, but these are highly dependent on the cellular background. The same is true for phenotypes observed after treatment with inhibitors for kinases regulating cofilin phosphorylation (ROCKs and LIMKs). Targeting the cofilin phosphorylation pathway might therefore not be a straightforward therapeutic option in glioblastoma. KW - chronophin KW - cofilin KW - vitamin metabolism KW - glioma Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234645 VL - 18 ER - TY - THES A1 - Lee, Kyeong-Hee T1 - Cofilin T1 - Cofilin N2 - This study has identified cofilin, an actin binding protein, as a control element in the reorganization of the actin cytoskeleton which is highly relevant for T lymphocyte activation. Cofilin is regulated in its activity by reversible phosphorylation which is inducible by stimulation through accessory receptors such as CD2 and CD28. First it could be demonstrated that accessory receptor triggering induces the transient association of cofilin with the actin cytoskeleton and that only the dephosphorylated form of cofilin possesses the capacity to bind cytoskeletal actin in vivo. PI3-kinase inhibitors block both the dephosphorylation of cofilin and its association with the actin cytoskeleton. Importantly, cofilin, actin, PI3-kinase and one of its substrates, namely phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) which can bind to cofilin, co-localize within CD2-receptor caps. The cofilin/F-actin interaction has been identified as a crucial regulatory element for receptor cap formation and the strength of signal transduction. To this end, appropriately designed cell permeable non-toxic peptides that are homologous to actin binding motifs of the human cofilin sequence were introduced into untransformed human peripheral blood T lymphocytes. These peptides competitively and dose dependently inhibit the activation induced interaction of cofilin with the actin cytoskeleton in vivo. By this approach it was possible to study, for the first time, the functional consequences of this interaction in immunocompetent T cells. The present data demonstrate that inhibition of the actin/cofilin interaction in human T lymphocytes by means of these cofilin derived peptides abolishes receptor cap formation and strongly modulates functional T cell responses such as T cell proliferation, interleukin-2 production, cell surface expression of CD69, gIFN production, and CD95L expression. Importantly, receptor independent activation by PMA and calcium ionophore circumvents these peptide produced inhibitory effects on lymphocyte stimulation and places the cofilin/actin interaction to a proximal step in the cascade of signaling events following T cell activation via surface signals. The present results are novel since as yet no information existed regarding the molecular elements which link cell surface receptor stimulation directly to the resulting reorganization of the actin cytoskeleton. N2 - Die vorliegende Arbeit hat gezeigt, dass Cofilin, ein aktin-bindendes Protein, als Kontrollelement bei der Reorganisation des Aktinzytoskeletts fungiert und damit von besonderer Bedeutung für die Aktivierung von T-Lymphozyten ist. Cofilin wird in seiner Aktivität durch reversible Phosphorylierung reguliert, die induzierbar ist über eine Stimulation durch akzessorische Rezeptoren wie CD2 und CD28. Es konnte gezeigt werden, dass eine Stimulation über akzessorische Rezeptoren zu einer transienten Assoziation von Cofilin mit dem Aktinzytoskelett führt und dass nur die dephosphorylierte Form von Cofilin die Fähigkeit besitzt, in vivo an das Aktinzytoskelett zu binden. Inhibitoren der PI3-Kinase blockieren sowohl die Dephosphorylierung von Cofilin, als auch seine Assoziation mit dem Aktinzytoskelett. Hervorzuheben ist, dass Cofilin, zusammen mit Aktin, PI3-Kinase und einem ihrer Substrate, Phosphatidylinositol 4,5-Bisphosphat (PtdIns(4,5)P2), welches an Cofilin binden kann, mit CD2-Rezeptor-"Caps" kolokalisiert. Die Cofilin/F-Aktin-Interaktion konnte als wesentliches regulatorisches Element für die Rezeptor-"Cap"-bildung und die Stärke der Signalübertragung identifiziert werden. Hierzu wurden maßgeschneiderte zellpermeable Peptide, welche homolog zu aktin-bindenden Motiven der humanen Cofilin-Sequenz sind, in nicht-transformierte humane periphere T-Lymphozyten eingeschleust. Diese Peptide hemmen kompetitiv und dosisabhängig die durch Aktivierung induzierte Interaktion von Cofilin mit dem Aktinzytoskelett in vivo. Dieser Ansatz ermöglichte erstmals die Untersuchung funktioneller Konsequenzen dieser Interaktion in immunkompetenten T-Zellen. Die vorgelegten Ergebnissse zeigen, dass die Blockierung der Interaktion von Cofilin mit dem Aktinzytoskelett in humanen T-Zellen mittels von Cofilin abgeleiteter Peptide die Rezeptor-"Cap"-bildung verhindert, sowie zu einer deutlichen Modulation funktioneller T-Zell-Antworten, wie T-Zellproliferation, Interleukin-2-Produktion, Zelloberflächenexpression von CD69, gIFN-Produktion und Expression von CD95L führt. Hervorzuheben ist, dass rezeptor-unabhängige Aktivierung über PMA und Calciumionophor diese durch Peptide verursachten inhibitorischen Effekte umgeht und die Cofilin/Aktin-Interaktion somit als einen proximalen Schritt in der über Oberflächenmoleküle vermittelten Signalübertragungskaskade in T-Zellen identifiziert. Die vorgestellten Ergebnisse sind neu, da bisher keine Informationen bezüglich der molekularen Elemente existierten, welche eine Stimulation von Zelloberflächenrezeptoren direkt mit der Reorganisation des Aktinzytoskeletts verbinden. KW - T-Lymphozyt KW - Aktivierung KW - Actin KW - Cofilin KW - Lymphozytentransformation KW - Cofilin KW - Aktin-Zytoskelett KW - T-Zell-Aktivierung KW - PI3-Kinase KW - Apoptose KW - cofilin KW - actin cytoskeleton KW - T cell activation KW - PI3-kinase KW - apoptosis Y1 - 1999 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-1681 ER -